Clinical Trial

RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 15, 2024 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this imaging substudy of RESTORE trial is to demonstrate the superiority of drug-coated balloon (DCB) treatment on non-flow limited vulnerable plaque as compared to guideline-directed medical therapy (GDMT) in improving plaque stabilization in patients with acute coronary syndrome.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06449274
Lead Sponsor Harbin Medical University
Collaborators: Shanghai Shenqi Medical Technology Co., Ltd
Conditions Acute Coronary Syndrome (ACS)
Enrollment 180 participants
Start Date 2024-06-25
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2024-07-15